The Impact of Medical TV Drama in Improving Literacy on Neurocysticercosis

NCT07208656 | Not Yet Recruiting

• 1 other identifier: CUL25/NCC/001
• Study Type: interventional
• Target: 60
• Locations: 0 countries
• Sites: N/A

Brief Summary

This randomized controlled trial evaluates whether exposure to a medical television drama improves knowledge of neurocysticercosis (NCC) among young adults. Sixty participants aged 18-35 will be randomly assigned to either an intervention group, which will watch a medically relevant TV episode (House M.D., Season 1, Episode 1), or a control group with no media exposure. Both groups will complete pre- and post-test questionnaires assessing knowledge of NCC. The primary outcome is change in NCC-related knowledge. Secondary outcomes include motivation to seek further health information and perceived credibility of the media source

Conditions

Neurocysticercosis; Health Literacy; Epilepsy

Outcome Measures

Primary Outcomes (1)

• Change in Neurocysticercosis (NCC) Knowledge Score

  Knowledge of neurocysticercosis (NCC) will be assessed using the Neurocysticercosis Knowledge Questionnaire, a 10-item multiple-choice instrument developed for this study. Each correct answer is scored as 1 point, and each incorrect or "I don't know" response is scored as 0 points. The total score represents the sum of correct answers, with a minimum possible score of 0 and a maximum possible score of 10. Higher scores indicate better knowledge of NCC across domains such as cause, transmission, symptoms, prevention, and treatment. The primary outcome is the change in total knowledge score from baseline (pre-test) to immediately post-intervention, compared between the intervention and control groups

  Baseline and immediately post-intervention (within 1 hour)

Secondary Outcomes (3)

• Retention of Neurocysticercosis Knowledge

  4 weeks post-intervention.

• Perceived Credibility of the Medical TV Drama

  Immediately post-intervention (within 1 hour).

• Motivation to Seek Further Health Information

  Immediately post-intervention (within 1 hour).

Study Arms (2)

Intervention (House M.D. Episode)

EXPERIMENTAL

Participants in this arm will watch a selected episode of the medical television drama House M.D. (Season 1, Episode 1), which features a dramatized case of neurocysticercosis. The intervention is designed to provide narrative-based exposure to information relevant to the disease. Participants will complete pre- and post-intervention questionnaires assessing knowledge, motivation, and credibility.

Behavioral: Medical TV Drama Episode (House M.D.)

Control (No Episode)

NO INTERVENTION

Participants in this arm will not receive any exposure to medical television content during the study period. They will complete the same pre- and post-intervention questionnaires as the intervention group, allowing comparison of changes in knowledge, motivation, and credibility.

Interventions

Medical TV Drama Episode (House M.D.) BEHAVIORAL

Participants in the experimental group will watch a selected episode of the medical drama House M.D. (Season 1, Episode 1), which includes a dramatized storyline relevant to neurocysticercosis. The episode is intended to deliver narrative-based health education. After viewing, participants will complete post-test questionnaires assessing changes in knowledge, motivation, and credibility compared to pre-test results.

Also known as: House M.D. Season 1, Episode 1

Intervention (House M.D. Episode)

Eligibility Criteria

• Age: 18 Years - 35 Years
• Sex: all
• Healthy Volunteers: Yes
• Age Groups: Adult (18-64)

You may qualify if:

• Aged 18 to 35 years
• Proficient in English (reading and comprehension)
• Has access to a stable internet connection
• Possesses a screen-enabled device (e.g., smartphone, tablet, or computer)
• Has access to the Netflix streaming platform

You may not qualify if:

• Has formal education in medical or health sciences
• Has a prior diagnosis of neurocysticercosis (NCC)
• Has previously participated in any NCC-related health literacy or awareness program
• Lacks access to the Netflix movie platform
• Below 18 years or above 35 years of age

Sponsors & Collaborators

• Cephas Health Research Initiative Inc, Ibadan, Nigeria: lead

MeSH Terms

Conditions

Neurocysticercosis; Epilepsy

Condition Hierarchy (Ancestors)

Central Nervous System Helminthiasis; Central Nervous System Parasitic Infections; Central Nervous System Infections; Infections; Parasitic Diseases; Cysticercosis; Taeniasis; Cestode Infections; Helminthiasis; Central Nervous System Diseases; Nervous System Diseases; Brain Diseases

Central Study Contacts

Kehinde Kanmodi, PhD

CONTACT

+15059006972; kanmodikehinde@yahoo.com

Emeka Okeke, PhD

CONTACT

+447767635349; konebemeka@gmail.com

Study Design

• Study Type: interventional
• Phase: not applicable
• Allocation: RANDOMIZED
• Masking: NONE
• Masking Details: This is an open-label trial; no blinding was performed.
• Purpose: PREVENTION
• Intervention Model: PARALLEL
• Sponsor Type: NETWORK
• Responsible Party: PRINCIPAL INVESTIGATOR
• PI Title: Dr.

Model Details: Two-arm, open-label, randomized controlled trial with parallel assignment.

Study Record Dates

• First Submitted: September 28, 2025
• First Posted: October 6, 2025
• Study Start: December 15, 2025
• Primary Completion: February 15, 2026
• Study Completion: April 15, 2026
• Last Updated: December 4, 2025

Record last verified: 2025-11

Data Sharing

• IPD Sharing: Will not share